The important function of DUSP16 in mediating sensitivity to chemotherapy in various types of cancers suggests that it could serve as a predictive marker for stratifying responsive patients, and as a target for the development of therapies to improve the effectiveness of chemotherapy. This evidence concerns the gene DUSP16 and cancer.